Kidney Cancer, Version 2.2024 Featured Updates to the NCCN Guidelines

Robert J. Motzer; Eric Jonasch; Neeraj Agarwal; Ajjai Alva; Hilary Bagshaw; Michael Baine; Kathryn Beckermann; Maria I. Carlo; Toni K. Choueiri; Brian A. Costello; Ithaar H. Derweesh; Arpita Desai; Yasser Ged; Saby George; John L. Gore; Andrew Gunn; Naomi Haas; Michael Johnson; Payal Kapur; Jennifer King; Christos Kyriakopoulos; Elaine T. Lam; Primo N. Lara; Clayton Lau; Bryan Lewis; David C. Madoff; Brandon Manley; M. Dror Michaelson; Amir Mortazavi; Lee Ponsky; Sundhar Ramalingam; Brian Shuch; Zachary L. Smith; Jeffrey Sosman; Randy Sweis; Matthew Zibelman; Ryan Schonfeld; Mary Elizabeth Stein; Lisa A. Gurski

doi:10.6004/jnccn.2024.0008

Kidney Cancer, Version 2.2024 Featured Updates to the NCCN Guidelines

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Ajjai Alva, Hilary Bagshaw, Michael Baine, Kathryn Beckermann, Maria I. Carlo, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Arpita Desai, Yasser Ged, Saby George, John L. Gore, Andrew Gunn, Naomi Haas, Michael Johnson, Payal Kapur, Jennifer KingChristos Kyriakopoulos, Elaine T. Lam, Primo N. Lara, Clayton Lau, Bryan Lewis, David C. Madoff, Brandon Manley, M. Dror Michaelson, Amir Mortazavi, Lee Ponsky, Sundhar Ramalingam, Brian Shuch, Zachary L. Smith, Jeffrey Sosman, Randy Sweis, Matthew Zibelman, Ryan Schonfeld, Mary Elizabeth Stein, Lisa A. Gurski

Genitourinary Medical Oncology

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on the systemic therapy options for patients with advanced RCC and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Kidney Cancer.

Original language	English (US)
Pages (from-to)	4-16
Number of pages	13
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	22
Issue number	1
DOIs	https://doi.org/10.6004/jnccn.2024.0008
State	Published - Feb 2024

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2024.0008

Cite this

Motzer, R. J., Jonasch, E., Agarwal, N., Alva, A., Bagshaw, H., Baine, M., Beckermann, K., Carlo, M. I., Choueiri, T. K., Costello, B. A., Derweesh, I. H., Desai, A., Ged, Y., George, S., Gore, J. L., Gunn, A., Haas, N., Johnson, M., Kapur, P., ... Gurski, L. A. (2024). Kidney Cancer, Version 2.2024 Featured Updates to the NCCN Guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 22(1), 4-16. https://doi.org/10.6004/jnccn.2024.0008

Motzer, RJ, Jonasch, E, Agarwal, N, Alva, A, Bagshaw, H, Baine, M, Beckermann, K, Carlo, MI, Choueiri, TK, Costello, BA, Derweesh, IH, Desai, A, Ged, Y, George, S, Gore, JL, Gunn, A, Haas, N, Johnson, M, Kapur, P, King, J, Kyriakopoulos, C, Lam, ET, Lara, PN, Lau, C, Lewis, B, Madoff, DC, Manley, B, Michaelson, MD, Mortazavi, A, Ponsky, L, Ramalingam, S, Shuch, B, Smith, ZL, Sosman, J, Sweis, R, Zibelman, M, Schonfeld, R, Stein, ME & Gurski, LA 2024, 'Kidney Cancer, Version 2.2024 Featured Updates to the NCCN Guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 22, no. 1, pp. 4-16. https://doi.org/10.6004/jnccn.2024.0008

@article{67008dac2c46438d8dcee827f26c989a,

title = "Kidney Cancer, Version 2.2024 Featured Updates to the NCCN Guidelines",

abstract = "The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on the systemic therapy options for patients with advanced RCC and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Kidney Cancer.",

author = "Motzer, {Robert J.} and Eric Jonasch and Neeraj Agarwal and Ajjai Alva and Hilary Bagshaw and Michael Baine and Kathryn Beckermann and Carlo, {Maria I.} and Choueiri, {Toni K.} and Costello, {Brian A.} and Derweesh, {Ithaar H.} and Arpita Desai and Yasser Ged and Saby George and Gore, {John L.} and Andrew Gunn and Naomi Haas and Michael Johnson and Payal Kapur and Jennifer King and Christos Kyriakopoulos and Lam, {Elaine T.} and Lara, {Primo N.} and Clayton Lau and Bryan Lewis and Madoff, {David C.} and Brandon Manley and Michaelson, {M. Dror} and Amir Mortazavi and Lee Ponsky and Sundhar Ramalingam and Brian Shuch and Smith, {Zachary L.} and Jeffrey Sosman and Randy Sweis and Matthew Zibelman and Ryan Schonfeld and Stein, {Mary Elizabeth} and Gurski, {Lisa A.}",

note = "Publisher Copyright: {\textcopyright} 2024 National Comprehensive Cancer Network{\textregistered} (NCCN{\textregistered}), All rights reserved. The NCCN Guidelines and the illustrations herein may not be reproduced in any form without the express written permission of NCCN.",

year = "2024",

month = feb,

doi = "10.6004/jnccn.2024.0008",

language = "English (US)",

volume = "22",

pages = "4--16",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "1",

}

TY - JOUR

T1 - Kidney Cancer, Version 2.2024 Featured Updates to the NCCN Guidelines

AU - Motzer, Robert J.

AU - Jonasch, Eric

AU - Agarwal, Neeraj

AU - Alva, Ajjai

AU - Bagshaw, Hilary

AU - Baine, Michael

AU - Beckermann, Kathryn

AU - Carlo, Maria I.

AU - Choueiri, Toni K.

AU - Costello, Brian A.

AU - Derweesh, Ithaar H.

AU - Desai, Arpita

AU - Ged, Yasser

AU - George, Saby

AU - Gore, John L.

AU - Gunn, Andrew

AU - Haas, Naomi

AU - Johnson, Michael

AU - Kapur, Payal

AU - King, Jennifer

AU - Kyriakopoulos, Christos

AU - Lam, Elaine T.

AU - Lara, Primo N.

AU - Lau, Clayton

AU - Lewis, Bryan

AU - Madoff, David C.

AU - Manley, Brandon

AU - Michaelson, M. Dror

AU - Mortazavi, Amir

AU - Ponsky, Lee

AU - Ramalingam, Sundhar

AU - Shuch, Brian

AU - Smith, Zachary L.

AU - Sosman, Jeffrey

AU - Sweis, Randy

AU - Zibelman, Matthew

AU - Schonfeld, Ryan

AU - Stein, Mary Elizabeth

AU - Gurski, Lisa A.

N1 - Publisher Copyright: © 2024 National Comprehensive Cancer Network® (NCCN®), All rights reserved. The NCCN Guidelines and the illustrations herein may not be reproduced in any form without the express written permission of NCCN.

PY - 2024/2

Y1 - 2024/2

N2 - The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on the systemic therapy options for patients with advanced RCC and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Kidney Cancer.

AB - The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on the systemic therapy options for patients with advanced RCC and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Kidney Cancer.

UR - http://www.scopus.com/inward/record.url?scp=85185860641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85185860641&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2024.0008

DO - 10.6004/jnccn.2024.0008

M3 - Article

C2 - 38394781

AN - SCOPUS:85185860641

SN - 1540-1405

VL - 22

SP - 4

EP - 16

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 1

ER -

Kidney Cancer, Version 2.2024 Featured Updates to the NCCN Guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this